マインドウォークHDの適時開示

6-K 1 agm_oct_2025_voting_resu.htm 6-K 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2025.

Commission File Number: 001-39530

MindWalk Holdings Corp.

Industrious 823 Congress Ave Suite 300 Austin, Texas 78701

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.


Form 20-F ☒	Form 40-F ☐

INCORPORATION BY REFERENCE

Exhibits 99.1 of this Form 6-K are incorporated by reference into the Registration Statement on Form S-8 (File No. 333-290949) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312) of the Registrant, MindWalk Holdings Corp.

EXHIBIT INDEX



Exhibit	Description
99.1	Report of Voting Results dated October 9, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



	MINDWALK HOLDINGS CORP.
Date: October 21, 2025

	By:	/s/ Jennifer Bath
	Name:	Jennifer Bath
	Title:	Chief Executive Officer

EX-99.1 2 hyft-ex99_1.htm EX-99.1 EX-99.1

Report of Voting Results

Submitted Pursuant to

Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations

In accordance with Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations, this report describes the matters voted upon and the outcome of the votes at the annual general meeting of shareholders of MindWalk Holdings Corp. (the "Corporation") held on October 9, 2025, via live webcast (the "Meeting"). Each of the matters is described in greater detail in the Corporation's management information circular dated September 12, 2025 (the "Circular").

(a)

The number of directors was set at four. The following are the voting results on this matter:


FOR	% FOR	AGAINST	% AGAINST
Number of Directors 10,999,231	81.01%	2,578,940	18.99%

(b)

In the Circular, management of the Corporation proposed four nominees for election as directors of the Corporation for the ensuing year or until their successors are duly elected or appointed. The Corporation’s majority voting policy stipulates that any director nominee who receives more votes withheld than in favor must tender their resignation to the board. In this instance, Kamil Isaev did not achieve the required majority and, in accordance with the policy, submitted his resignation following the meeting. The Board of Directors voted to accept Isaev’s resignation, consistent with the Company’s governance guidelines and in accordance with the meeting’s voting results. The voting results that formed the basis for this decision are summarized below:


	FOR	% FOR	WITHHELD	% WITHHELD
Jennifer Bath	14,466,159	82.19%	3,135,042	17.81%
Kamil Isaev	5,530,006	32.31%	11,581,891	67.68%
Jon Lieber	16,657,783	97.34%	454,114	2.65%
Dirk Witters	13,139,325	76.78%	3,972,571	23.21%

(c)

Davidson & Company LLP was appointed as the Corporation's auditors and the directors were authorized to fix the remuneration to be paid to the auditors. The following are the voting results on this matter:

      
FOR

     % 
FOR

WITHHELD

     % 
WITHHELD

     Appointment of Auditors

     22,371,219

     95.71%

     1,001,605

     4.29%

Dated this 9th day of October 2025.


IMMUNOPRECISE ANTIBODIES LTD.


By:	/s/ Jennifer Bath
Name:	Jennifer Bath
Title:	Chief Executive Officer